|
|
|
|
|
|
Invivo Theraptc Cmn (NVIV)
|
|
2.75 0 (+0.00%)
|
6/28/2017 4:00pm
|
|
Open:
|
3.05
|
Pre. Close:
|
2.75
|
|
High:
|
3.10
|
Low:
|
2.70
|
|
Volume:
|
884,099
|
Market Cap:
|
88.42M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
3.13 - 3.19
|
3.19 - 3.32
|
|
Low:
|
2.51 - 2.57
|
2.57 - 2.69
|
|
Close:
|
2.64 - 2.72
|
2.72 - 2.9
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-28 4:39:12 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 3.63 One year: 4.50
|
|
Support:
|
Support1: 1.90 Support2: 1.58
|
|
Resistance:
|
Resistance1:
3.11 Resistance2: 3.85
|
|
Pivot:
|
2.48
|
|
Moving Averages:
|
MA(5): 2.91  MA(20): 2.40
MA(100): 3.47 MA(250): 4.72
|
|
MACD:
|
MACD(12,26):
0.07 Signal(12,26,9): -0.03
|
|
%K %D:
|
%K(14,3): 40.17 %D(3): 46.44
|
|
RSI:
|
RSI(14): 53.24
|
|
52-Week:
|
High: 7.94
Low: 1.90 Change(%): -52.7
|
|
Average Vol(K):
|
3-Month: 343
10-Days 687
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.NVIV has closed below upper band by 34.6%. Bollinger Bands are 93.9% wider than normal. The large width of the bands suggest high volatility as compared to NVIV's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Wed, 28 Jun 2017 16:07:30 GMT
InVivo Therapeutics (NVIV) Reports Two Spinal Injury Milestones
Mon, 09 Jan 2017 18:45:00 GMT
The Backdrop For PixarBio's Offer To Acquire InVivo Therapeutics
Mon, 22 Aug 2016 15:28:33 GMT
Has InVivo Therapeutics Developed A New Standard Of Spinal Cord Care?
Tue, 27 Jun 2017 21:22:30 GMT
InVivo Therapeutics Holdings Corp. (NVIV) Soars 7.84% on June 27
Tue, 20 Jun 2017 18:38:39 GMT
Mid-Afternoon Market Update: Fang Drops After Q1 Results; Invivo Therapeutics ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
